Seeking Alpha

Bohsie

 
View as an RSS Feed
View Bohsie's Comments BY TICKER:
Latest  |  Highest rated
  • The Case Of Northwest Biotherapeutics' Missing DMC Recommendation [View article]
    Well, 25% is pathetic if you could have had 250% when it was at $2 - $3 a share, or even higher!!! Yeah could job on that investment!
    Jan 21, 2015. 03:04 PM | Likes Like |Link to Comment
  • Why Netflix Is Not Overvalued [View article]
    None of the Top Movies? Here are just some of the Disney movies available on Netflix:

    - Pocahontas (Princess Movie)
    - Hercules
    - Up
    - Lilo & Stitch
    - Mulan (Princess Movie)
    -Alice in Wonderland
    - Lady & The Tramp
    - Emperor's New Groove
    - 101 Dalmationas,
    - Fox and the Hound
    - Ratatouille
    - Brave (NEW PRINCESS MOVIE)
    -Dumbo
    -Mary Poppins
    - Hunchback of Notre Dame
    - Sword in the Stone

    Plus 30 or so more that I havent listed like classics like Robin Hood.

    And those are just to name a few. No Frozen isnt available yet. It came out a 1 year ago (and 2 months), and so it is considered a new release still. And with its monster success, it might be a while before they release it to Netflix, though I am sure it will be on there by the end of 2015.
    Jan 21, 2015. 02:45 PM | 1 Like Like |Link to Comment
  • Why Netflix Is Not Overvalued [View article]
    No my point was that TV was going to be offered on the Internet and if you think Netflix will not join the club or segment their offerings to other channels, then you are sadly mistaken.

    Actually Netflix DOES have a deal with Disney. Obviously you havent been on Netflix lately. You can watch many of the Disney movies on their now.

    I remember when you said watching the Superbowl on live streaming would be a pipe dream. I could easily see a Netflix or Dish streaming company getting that here soon.

    I LOVE BEING RIGHT!!!
    Jan 8, 2015. 01:25 AM | Likes Like |Link to Comment
  • Netflix Is Still Wildly Undervalued [View article]
    LOVE BEING RIGHT! DISH is now going to offer TV channels streamed including ESPN!!!

    I wonder what will happen to Netflix stock once they offer a TV service as well? Or segment their service to TV channels as well.

    http://cnet.co/14fDNnU
    Jan 5, 2015. 11:02 PM | Likes Like |Link to Comment
  • Why Netflix Is Not Overvalued [View article]
    I LOVE BEING RIGHT! Looks like Dish is going to be the first one to offer internet TV, including ESPN. Pretty much just what I stated but they jumped the gun over Netflix. What Netflix follow suit soon here, and with the high number of subscribers, they will have the advantage.

    Pauldeba, looks like my Pipe Dream became a reality!!

    http://cnet.co/14fDNnU
    Jan 5, 2015. 10:59 PM | Likes Like |Link to Comment
  • The Case Of Northwest Biotherapeutics' Missing DMC Recommendation [View article]
    Oh wow, you are up 0.14 cents on IMUC. Good pick!!!
    Dec 15, 2014. 10:48 PM | 1 Like Like |Link to Comment
  • The Time Is Now For Northwest Biotherapeutics [View article]
    Saw a great 60 minutes that covers Patrick Soon-Shiong, one of the richest doctors in the world, and he seems to have a very amazing view on finding a cure on cancer (or atleast mapping which cure to use). One of his insights is Immunotherapy. Very interestings!

    http://cbsn.ws/13sqQHm

    http://read.bi/13sqQHp
    Dec 15, 2014. 10:38 PM | 5 Likes Like |Link to Comment
  • The Time Is Now For Northwest Biotherapeutics [View article]
    Yes, I do not take much weight in it on its own. And maybe the article was written in a way that could be taken incorrectly. If it was a double blind though, I would think that it wouldnt have been stated at all that he was in the trial.

    I agree you can not take much weight in his OS as he could be an outlier. However, being his age, and having an OS of 15 months seems to be quite good. I would love to see what the OS is for patients aged 60+ . Remember that younger GBM patients usually pushed the OS above the 18 month mark, and reversely, older patients dropped that OS average. So stating that Demeger's 15 month OS was greater than the average of 60+ GBM patients would not be a false statement. Take from that what you will.
    Nov 3, 2014. 12:11 PM | 2 Likes Like |Link to Comment
  • The Time Is Now For Northwest Biotherapeutics [View article]
    Steven,

    It clearly states that he received the vaccine:

    http://bit.ly/1Ed81ox
    Nov 3, 2014. 10:28 AM | Likes Like |Link to Comment
  • The Time Is Now For Northwest Biotherapeutics [View article]
    Just want to add here, as I read today that sadly Robert Demeger the actor that was diagnosed with GBM the first half of 2013 and received the DCVax-L treatment died Sept 14, 2014. He originally had his tumor removed June 2013, and then had DCVax-L treatment. His OS would have been ~ 16 months, which was above the average of 12 - 14 months for SOC. It is a sad day, and as much as I would have loved to see Robert reprise his acting career and move his OS past 2 years, and even though it is anecdotal, it definitely does not lean negatively (and could even be seen as somewhat positive as an increase in OS compared to SOC).
    Oct 30, 2014. 06:35 PM | 2 Likes Like |Link to Comment
  • Northwest Bio's Latest Financing Abuses Its Shareholders: Is The Charade Over? [View article]
    Adam,

    What are you NOT confident about? You seem to be confident about everything you speak off. Its almost like you have little man syndrome. I bet you are not very tall at all, and over compensate for this in your articles. Am I correct?
    Oct 20, 2014. 11:02 AM | 2 Likes Like |Link to Comment
  • The Case Of Northwest Biotherapeutics' Missing DMC Recommendation [View article]
    Here are more links to other sites that show the same equation. One's even a university. Funny how they all have the same equation. You cant's explain this any simpler, because you dont understand statistics.

    http://bit.ly/ZDUUgI

    http://bit.ly/ZDUUgK

    You are way over your head P Man. If I could, I would scan a Stats book for you and upload it. And low and behold, it would have the exact same equation. But go ahead, think that the sample size has no bearing on the equation.
    Oct 15, 2014. 12:29 PM | Likes Like |Link to Comment
  • Northwest Bio: The Data Monitoring Committee Addresses The Status Of The DCVax-L Trial [View article]
    And you aren't emotionally involved in IMUC? That's the pot calling the tea kettle black!
    Oct 15, 2014. 12:09 PM | 1 Like Like |Link to Comment
  • Northwest Bio: The Data Monitoring Committee Addresses The Status Of The DCVax-L Trial [View article]
    rkmatters,

    Termizolomide, currently the standard of care for GBM, was approved on 2 months increase in survivability in their phase III trial. So that is the benchmark right now. GBM is so aggressive, and so deadly that even baby steps in treatment breakthroughs are considered.
    Oct 15, 2014. 12:07 PM | 1 Like Like |Link to Comment
  • Northwest Bio: The Data Monitoring Committee Addresses The Status Of The DCVax-L Trial [View article]
    P Man,

    You have already shown you do not understand Statistics. How many times have I stated; the current Standard of Care, Termizolomide, was approved with 2 months increase. 2 MONTHS INCREASE. Not sure if you read that.

    2 MONTH INCREASE was what the phase III clinical trial showed. Termizolomide showed statistical significance in increasing OS by 2 months, and it was approved and is now the Standard of Care. With a disease like GBM, 2 months is almost a 15% increase in survivability.

    Maybe to you it doesnt seem clinically significant, but for those with brain cancer, it does. Also, remember, the average is 2 month increase, for some it is much more than that. So the answer is yes, someone pay $100,000 for greater than 2 months survival over the standard of care, well, if 6 months, or a year more is a possibility. This also adds to the fact not only do you not understand statistics, you do not understand the industry.
    Oct 15, 2014. 12:04 PM | 1 Like Like |Link to Comment
COMMENTS STATS
896 Comments
940 Likes